Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeman, L. M.
Right arrow Articles by Rush, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, L. M.
Right arrow Articles by Rush, J. E.

The Journal of Nutrition Vol. 128 No. 12 December 1998, pp. 2768S-2770S

Antioxidant Status in Dogs with Idiopathic Dilated Cardiomyopathy1,2

Lisa M. Freeman3, Don J. Brown, and John E. Rush

Department of Medicine, Tufts University School of Veterinary Medicine, North Grafton, MA 01536 USA

KEY WORDS: antioxidant · dilated cardiomyopathy · glutathione peroxidase · dogs

    INTRODUCTION
Introduction
References

Free radicals, metabolites of oxygen metabolism, are produced under normal conditions, but their rate of production does not exceed the capacity of the body to catabolize them. It is only when the natural defenses are overwhelmed that free radical damage occurs. Therefore, the host's endogenous antioxidant system plays a major role in the prevention or limitation of myocardial damage. Endogenous antioxidants include enzymatic antioxidants (e.g., superoxide dismutase or glutathione peroxidase), free radical scavengers (e.g., vitamins A, C or E) and metal chelators. Antioxidants also can be derived exogenously through the diet or through the use of supplements.

Free radical-induced injury has been implicated in the development of a number of cardiac diseases, including coronary artery disease, myocardial infarction and some forms of cardiomyopathy in people and laboratory animals (Kaul et al. 1993). Free radicals not only have cytotoxic effects on the myocardium, but also act as negative inotropes (Prasad et al. 1993). Altered antioxidant status has been identified in an aortic banding model of congestive heart failure, with elevated levels during cardiac hypertrophy and decreased levels in failure (Dhalla and Singal 1994, Gupta and Singal 1989). Similar changes have been seen in other human diseases such as inflammatory bowel disease and human immunodeficiency virus (Delmas-Beauvieux et al. 1996, Hoffenberg et al. 1997). Elevated mean vitamin A concentration was found in cats with dilated cardiomyopathy compared with healthy controls (Fox et al. 1993). Whether these alterations contribute to disease progression or reflect a compensatory response to increased free radical stress is unclear at present.

The purpose of this pilot study was to determine antioxidant status in dogs with idiopathic dilated cardiomyopathy (IDCM)4 compared with healthy controls.

Materials and methods. 

Antioxidant status in canine IDCM.  All dogs were client-owned animals. A diagnosis of IDCM was based on the presence of left atrial enlargement and a fractional shortening <28% (<22% in Doberman pinschers) on 2-D and M-mode echocardiography. Controls were age- and weight-matched to the IDCM dogs. Dogs with major concurrent diseases, such as cancer, chronic renal failure and hepatic failure were excluded from the study. Owners signed a consent form before enrolling their dogs in the study. The study was approved by the Tufts University Animal Care and Use Committee.

Blood (10 mL) was collected in EDTA, centrifuged and separated within 20 min. Fasting levels of vitamins A (retinol), C (ascorbic acid) and E (beta -tocopherol) were measured in plasma; glutathione peroxidase and superoxide dismutase were measured in washed erythrocytes. Vitamins A, C and E were determined by reverse-phase HPLC, and glutathione peroxidase was analyzed using a Cobas Fara II centrifugal analyzer (Roche Diagnostics Systems, Nutley, NJ). Superoxide dismutase was determined by a commercial spectrophotometric assay (SOD-525, Bioxytech, Cedex, France). Dietary vitamins A and E were calculated based on manufacturer's data (IU/kg diet on a dry matter basis) for dogs eating commercial dog foods. One dog, which ate a homemade diet, was excluded from determinations of dietary vitamins. Mean antioxidant concentrations between the IDCM and control groups were compared using Student's t test; Pearson correlation was used to identify potential correlations between disease severity and antioxidant concentrations. Results were considered significant when the two-tailed P- value was < 0.05. 

 
View this table:
[in this window] [in a new window]
 
Table 1. Mean echocardiographic measurements in dogs with idiopathic dilated cardiomyopathy (n = 12).

 
View this table:
[in this window] [in a new window]
 
Table 2. Mean circulating antioxidant concentrations in dogs with idiopathic dilated cardiomyopathy (IDCM) and controls1


View larger version (20K):
[in this window]
[in a new window]
 
Fig 1. Comparison of disease severity [based on end-systolic volume index (ESVI)] and glutathione peroxidase (GPX) concentrations in dogs with idiopathic dilated cardiomyopathy (n = 11) and controls (n = 10); *ESVI = (left ventricular internal dimension in systole)3/body surface area.

Results.  Twelve dogs with IDCM and 11 healthy controls were enrolled in the study. Mean age of the IDCM dogs was 8.9 ± 2.5 y compared with 7.9 ± 1.9 y in the control group (P = 0.21). Body weight also was not different between the groups (46.0 ± 18.3 kg for the IDCM group vs. 40.2 ± 6.9 kg for the controls; P = 0.57). All control dogs and 11 of the 12 IDCM dogs ate commercial dry diets; one IDCM dog ate a homemade diet. In the IDCM group, one dog was classified as New York Heart Association (NYHA) Class I, four were NYHA Class II, five were NYHA Class III, and two were NYHA Class IV. An arrhythmia was detected in 11 of 12 IDCM dogs (and 0 of 11 controls). The arrhythmia was atrial fibrillation in six dogs and ventricular premature complexes in five dogs. Medication regimens included an angiotensin-converting enzyme inhibitor (ACEI) and a beta -blocker (n = 3); ACEI, furosemide, digoxin and a beta -blocker (n = 6); and ACEI, furosemide, digoxin and diltiazem (n = 3). Mean echocardiographic measurements in the IDCM group are shown in Table 1.

Circulating antioxidant levels are shown in Table 2. Erythrocyte glutathione perioxidase concentrations were measured in only 21 of 23 dogs due to technical difficulties (11 dogs with IDCM and 10 controls). Mean erythrocyte glutathione peroxidase concentration was significantly higher in IDCM dogs (159.5 ± 19.8 U/g Hb) compared with controls (138.4 ± 14.4 U/g Hb; P = 0.01). There was a trend for higher concentrations of plasma vitamin A and vitamin C in the IDCM group as well, but these did not reach significance (P = 0.12 and P = 0.11, respectively). There was no difference between groups in plasma vitamin E or erythrocyte superoxide dismutase. There was a trend for higher levels of dietary vitamin A in the IDCM group (32488 ± 11481 IU/kg) compared with the controls (22775 ± 3005 IU/kg; P = 0.07), although there was no correlation between dietary vitamin A and circulating vitamin A. There was no difference between groups in dietary vitamin E levels (343 ± 222 IU/kg for IDCM dogs vs. 275 ± 124 IU/kg for controls; P = 0.48).

Disease severity (NYHA Class) was related to circulating antioxidants. There was a significant correlation between disease severity and erythrocyte glutathione peroxidase, both when severity was measured by NYHA Class (r = 0.52, P = 0.02) and when severity was measured by end-systolic volume index (r = 0.60; P = 0.009; Fig. 1). New York Heart Association Class was associated with plasma vitamin C (r = 0.49; P = 0.02). Class also was correlated with dietary vitamin A (r = 0.47; P < 0.05). There was no significant correlation between disease severity and plasma vitamin A, plasma vitamin E, erythrocyte superoxide dismutase or dietary vitamin A.

Discussion.  The results of this pilot study suggest that alterations in some aspects of the endogenous antioxidant system exist in dogs with IDCM, especially for circulating glutathione peroxidase and vitamin C. These results contradict those found using a rodent model of cardiac hypertrophy, in which reduced levels of antioxidants were found in animals with congestive heart failure (Gupta and Singal 1989). The cause for this discrepancy is unknown, but it is likely related to the disease model because at least two human studies demonstrated elevated antioxidant concentrations in inflammatory bowel disease and human immunodeficiency virus (Delmas- Beauvieux et al 1996, Hoffenberg et al 1997). Whether these alterations, similar to those in our study, are a primary or secondary occurrence is currently unknown. Elevations in antioxidant levels may be a marker of a compensatory response to increased oxidant stress. The elevations also may be secondary to medications used in the therapy of IDCM. On the other hand, these alterations in antioxidant status may play a role in the development or progression of disease. Either way, further study of these changes is warranted.

This study also identified trends for higher dietary intakes of vitamin A in dogs with IDCM and a correlation between dietary vitamin A and disease severity. The most likely cause for these weak relationships is that as cardiac disease becomes more severe, a reduced-sodium cardiac diet is more likely to be prescribed. These diets tend to contain high levels of vitamin A. Additional studies will be necessary to determine whether circulating levels of antioxidants accurately reflect tissue concentrations. For example, there are known to be some differences in the myocardial vs. the circulating antioxidant system because catalase is produced only in very low levels in the heart (Janssen et al. 1993).

In summary, dogs with IDCM had elevated concentrations of erythrocyte glutathione peroxidase, which were correlated with disease severity. Plasma vitamin C and dietary vitamin A also correlated with disease severity. Future studies will be required to determine the significance of these findings, which may be secondary to IDCM and its therapy or may play an important role in the development and progression of the disease.

    FOOTNOTES
1   Presented as part of the Waltham International Symposium on Pet Nutrition and Health in the 21st Century, Orlando, FL, May 26-29, 1997. Guest editors for the symposium publication were Ivan Burger, Waltham Centre for Pet Nutrition, Leicestershire, UK and D'Ann Finley, University of California, Davis.
2   Supported in part by Hill's Pet Nutrition.
3   To whom correspondence should be addressed.
4   Abbreviations used: ACEI, angiotensin converting-enzyme inhibitor; IDCM, idiopathic dilated cardiomyopathy; NYHA, New York Heart Association.

    LITERATURE CITED
Introduction
References

0022-3166/98 $3.00 ©1998 American Society for Nutritional Sciences




This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeman, L. M.
Right arrow Articles by Rush, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, L. M.
Right arrow Articles by Rush, J. E.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]